Skip to content

Posterior Cruciate Retaining (PCR) Versus Posterior Cruciate Substituting (PCS) Total Knee Arthroplasty (TKA)

SCORPIO™ Posterior Stabilized Versus Posterior Retained Total Knee Arthroplasties: Long-term Functional and Radiographic Outcome

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02429856
Acronym
SCORPIO™
Enrollment
100
Registered
2015-04-29
Start date
1999-02-28
Completion date
2013-05-31
Last updated
2021-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthroplasty, Replacement, Knee, Knee Arthroplasty, Total

Brief summary

This randomized clinical trial (RCT) examined 10 year outcomes comparing SCORPIO™ Posterior Cruciate Substituting (PCS) versus Posterior Cruciate Retaining (PCR) Total Knee Arthroplasty (TKA) as the primary outcome.

Detailed description

RCT of 100 subjects undergoing primary TKA who were randomized to received either a SCORPIO™ PCS or PCR TKA. Subjects were evaluated pre-operatively and at 2 and 10 years post-operatively using the Western Ontario (WOMAC) Osteoarthritis Index, the RAND-36 and knee range of motion (2 years only). Complication and revision rates were also evaluated.

Interventions

DEVICESCORPIO™

subjects randomized at surgery to receive 1 of the 2 specified implants

Sponsors

University of Alberta
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* scheduled for primary TKA * non-inflammatory arthritis * intact Posterior Cruciate Ligament at the time of surgery

Exclusion criteria

* required bone grafting of either the femur or tibia * varus or valgus deformity of \> 15 degrees * previous high tibial osteotomy * unable to understand or comply with the study requirements * unable to provide signed informed consent

Design outcomes

Primary

MeasureTime frameDescription
Western Ontario McMaster (WOMAC) Osteoarthritis Index Pain10 years postoperativedisease-specific patient reported health related quality of life (pain and function) with 2 constructs (pain; function) each ranging from 0-100 points No total score is calculated; we report the WOMAC in reverse order to align with the RAND-36 scores where higher scores are considered better than lower scores
WOMAC Osteoarthritis Index Function10 yearsdisease-specific patient reported health related quality of life (pain and function) with 2 constructs (pain; function) each ranging from 0-100 points No total score is calculated; we report the WOMAC in reverse order to align with the RAND-36 scores where higher scores are considered better than lower scores

Secondary

MeasureTime frameDescription
RAND -36 Health Survey10 years postoperativegeneric patient reported health related quality of life measure with 8 dimensions of health - we report the physical function dimension only with scores ranging from 0-100 where higher scores indicate better physical function.
Revision Ratewithin 10 years of surgerynumber of participants with revision surgery (ie another surgery on the same knee) for any cause data obtained from patient report and regional administrative databases
Number of Complicationswithin 10 years of surgery
Knee Range of Motionknee ROM at 2 years postoperativeKnee Range of Motion measured as a calculated total of knee flexion + knee extension; measured in degrees

Countries

Canada

Participant flow

Participants by arm

ArmCount
PCS Group
SCORPIO™ Posterior Cruciate Ligament Substituting TKA prosthesis SCORPIO™: subjects randomized at surgery to receive 1 of the 2 specified implants
49
PCR Group
SCORPIO™ Posterior Cruciate Ligament Retaining TKA prosthesis SCORPIO™: subjects randomized at surgery to receive 1 of the 2 specified implants
51
Total100

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyDeath1213
Overall StudyLost to Follow-up65
Overall StudyWithdrawal by Subject11

Baseline characteristics

CharacteristicPCR GroupPCS GroupTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
51 Participants49 Participants100 Participants
Age, Categorical
Between 18 and 65 years
0 Participants0 Participants0 Participants
Age, Continuous69.2 years
STANDARD_DEVIATION 9.1
70.2 years
STANDARD_DEVIATION 8.4
69.7 years
STANDARD_DEVIATION 8.6
Region of Enrollment
Canada
51 Participants49 Participants100 Participants
Sex: Female, Male
Female
27 Participants22 Participants49 Participants
Sex: Female, Male
Male
24 Participants27 Participants51 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 490 / 51
serious
Total, serious adverse events
5 / 492 / 51

Outcome results

Primary

Western Ontario McMaster (WOMAC) Osteoarthritis Index Pain

disease-specific patient reported health related quality of life (pain and function) with 2 constructs (pain; function) each ranging from 0-100 points No total score is calculated; we report the WOMAC in reverse order to align with the RAND-36 scores where higher scores are considered better than lower scores

Time frame: 10 years postoperative

ArmMeasureValue (MEAN)Dispersion
PCS GroupWestern Ontario McMaster (WOMAC) Osteoarthritis Index Pain84.0 units on a scaleStandard Deviation 19.8
PCR GroupWestern Ontario McMaster (WOMAC) Osteoarthritis Index Pain78.3 units on a scaleStandard Deviation 24.5
Primary

WOMAC Osteoarthritis Index Function

disease-specific patient reported health related quality of life (pain and function) with 2 constructs (pain; function) each ranging from 0-100 points No total score is calculated; we report the WOMAC in reverse order to align with the RAND-36 scores where higher scores are considered better than lower scores

Time frame: 10 years

ArmMeasureValue (MEAN)Dispersion
PCS GroupWOMAC Osteoarthritis Index Function67.9 units on a scaleStandard Deviation 25.6
PCR GroupWOMAC Osteoarthritis Index Function72.7 units on a scaleStandard Deviation 23.3
Secondary

Knee Range of Motion

Knee Range of Motion measured as a calculated total of knee flexion + knee extension; measured in degrees

Time frame: knee ROM at 2 years postoperative

ArmMeasureValue (MEAN)Dispersion
PCS GroupKnee Range of Motion105.8 degreesStandard Deviation 13.5
PCR GroupKnee Range of Motion105.9 degreesStandard Deviation 13
Secondary

Number of Complications

Time frame: within 10 years of surgery

Population: These complications include the revisions already recorded.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
PCS GroupNumber of Complications6 Participants
PCR GroupNumber of Complications2 Participants
Secondary

RAND -36 Health Survey

generic patient reported health related quality of life measure with 8 dimensions of health - we report the physical function dimension only with scores ranging from 0-100 where higher scores indicate better physical function.

Time frame: 10 years postoperative

ArmMeasureValue (MEAN)Dispersion
PCS GroupRAND -36 Health Survey42.4 units on a scaleStandard Deviation 28.7
PCR GroupRAND -36 Health Survey50.3 units on a scaleStandard Deviation 29.3
Secondary

Revision Rate

number of participants with revision surgery (ie another surgery on the same knee) for any cause data obtained from patient report and regional administrative databases

Time frame: within 10 years of surgery

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
PCS GroupRevision Rate5 Participants
PCR GroupRevision Rate2 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026